Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1643160rdf:typepubmed:Citationlld:pubmed
pubmed-article:1643160lifeskim:mentionsumls-concept:C0005821lld:lifeskim
pubmed-article:1643160lifeskim:mentionsumls-concept:C0857305lld:lifeskim
pubmed-article:1643160lifeskim:mentionsumls-concept:C0162595lld:lifeskim
pubmed-article:1643160lifeskim:mentionsumls-concept:C0443146lld:lifeskim
pubmed-article:1643160lifeskim:mentionsumls-concept:C1145667lld:lifeskim
pubmed-article:1643160lifeskim:mentionsumls-concept:C0332240lld:lifeskim
pubmed-article:1643160pubmed:issue1lld:pubmed
pubmed-article:1643160pubmed:dateCreated1992-9-10lld:pubmed
pubmed-article:1643160pubmed:abstractTextWe recently reported that IgM antibody-related microparticles exist in some patients with idiopathic thrombocytopenic purpura (ITP) [14]. In this study, we investigated the relationship between antiphospholipid (cardiolipin and phosphatidylinositol) antibodies and microparticles in 56 ITP patients. We used an ELISA to detect anti-phospholipid antibodies. IgG antibodies against cardiolipin and phosphatidylinositol were detected in 13 and 12 patients, respectively. The titers of IgG antibodies against these phospholipids did not correlate with the platelet-associated IgG level or the platelet count. Next, we investigated the binding of anti-phospholipid antibodies to platelets and microparticles. Microparticles were obtained by incubating washed platelets with collagen plus thrombin. ITP plasma containing IgG-class anti-phospholipid antibodies showed significantly increase binding to microparticles compared with plasma without such antibodies (p less than 0.001). Our results suggest that anti-phospholipid antibodies could affect the function of platelet microparticles in ITP.lld:pubmed
pubmed-article:1643160pubmed:languageenglld:pubmed
pubmed-article:1643160pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1643160pubmed:citationSubsetIMlld:pubmed
pubmed-article:1643160pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1643160pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1643160pubmed:statusMEDLINElld:pubmed
pubmed-article:1643160pubmed:monthJullld:pubmed
pubmed-article:1643160pubmed:issn0939-5555lld:pubmed
pubmed-article:1643160pubmed:authorpubmed-author:YamaguchiKKlld:pubmed
pubmed-article:1643160pubmed:authorpubmed-author:SuzukiMMlld:pubmed
pubmed-article:1643160pubmed:authorpubmed-author:KidoHHlld:pubmed
pubmed-article:1643160pubmed:authorpubmed-author:NomuraSSlld:pubmed
pubmed-article:1643160pubmed:authorpubmed-author:YasunagaKKlld:pubmed
pubmed-article:1643160pubmed:authorpubmed-author:KokawaTTlld:pubmed
pubmed-article:1643160pubmed:authorpubmed-author:KawakatsuTTlld:pubmed
pubmed-article:1643160pubmed:authorpubmed-author:FukuroiTTlld:pubmed
pubmed-article:1643160pubmed:authorpubmed-author:YanabuMMlld:pubmed
pubmed-article:1643160pubmed:issnTypePrintlld:pubmed
pubmed-article:1643160pubmed:volume65lld:pubmed
pubmed-article:1643160pubmed:ownerNLMlld:pubmed
pubmed-article:1643160pubmed:authorsCompleteYlld:pubmed
pubmed-article:1643160pubmed:pagination46-9lld:pubmed
pubmed-article:1643160pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1643160pubmed:meshHeadingpubmed-meshheading:1643160-...lld:pubmed
pubmed-article:1643160pubmed:meshHeadingpubmed-meshheading:1643160-...lld:pubmed
pubmed-article:1643160pubmed:meshHeadingpubmed-meshheading:1643160-...lld:pubmed
pubmed-article:1643160pubmed:meshHeadingpubmed-meshheading:1643160-...lld:pubmed
pubmed-article:1643160pubmed:meshHeadingpubmed-meshheading:1643160-...lld:pubmed
pubmed-article:1643160pubmed:meshHeadingpubmed-meshheading:1643160-...lld:pubmed
pubmed-article:1643160pubmed:meshHeadingpubmed-meshheading:1643160-...lld:pubmed
pubmed-article:1643160pubmed:meshHeadingpubmed-meshheading:1643160-...lld:pubmed
pubmed-article:1643160pubmed:meshHeadingpubmed-meshheading:1643160-...lld:pubmed
pubmed-article:1643160pubmed:year1992lld:pubmed
pubmed-article:1643160pubmed:articleTitleAnti-phospholipid antibodies bind to platelet microparticles in idiopathic (autoimmune) thrombocytopenic purpura.lld:pubmed
pubmed-article:1643160pubmed:affiliationFirst Department of Internal Medicine, Kansai Medical University, Osaka, Japan.lld:pubmed
pubmed-article:1643160pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1643160pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1643160lld:pubmed